Keyphrases
Cystic Fibrosis
100%
Hereditary Hemorrhagic Telangiectasia
26%
Forced Expiratory Volume in 1 Second (FEV1)
25%
Patient Registry
17%
Pulmonary Arteriovenous Malformation
15%
Risk Factors
11%
Europe
9%
Disease Severity
9%
Epistaxis
9%
Pseudomonas Aeruginosa (P. aeruginosa)
9%
Propranolol
8%
Pulmonary Outcomes
8%
Pediatric
7%
Israeli
7%
Allergic Bronchopulmonary Aspergillosis
7%
Bronchopulmonary Dysplasia
7%
Lung Disease
7%
Cerebral Arteriovenous Malformation
7%
Lung Clearance Index
7%
Israel
7%
Respiratory Symptoms
7%
COVID-19
7%
Cardiopulmonary Exercise Testing
6%
Sputum Culture
6%
Pancreatic Insufficient
6%
Mycobacterium Tuberculosis (M. tb)
6%
Lung Function
6%
Palivizumab
6%
Pulmonary Function Test
6%
Elexacaftor-tezacaftor-ivacaftor
6%
Face Mask
6%
Spirometry
6%
Bronchoscopy
5%
Residual Function
5%
Hospitalization
5%
Extremely Premature Birth
5%
Symptomatic children
5%
Asthmatic children
5%
Preconception Carrier Screening
5%
Dry Powder Inhaler
5%
Multicenter Cohort Study
5%
Clinical Characteristics
5%
Sputum
5%
Pulmonary Function
5%
Post-infection
5%
Medicine and Dentistry
Cystic Fibrosis
77%
Hereditary Hemorrhagic Telangiectasia
21%
Pediatrics
18%
Silo-Filler's Disease
18%
Prevalence
17%
Pulmonary Arteriovenous Fistula
15%
Patient Registry
14%
Forced Expiratory Volume
11%
Cohort Analysis
11%
Infection
11%
Diseases
11%
Lung
10%
Prematurity
9%
Pseudomonas aeruginosa
9%
Exercise Test
8%
Asthma
8%
Patient with Cystic Fibrosis
7%
Lung Clearance
7%
Lung Dysplasia
7%
Atypical Mycobacterium
6%
COVID-19
6%
Palivizumab
6%
Body Mass Index
6%
Bronchoscopy
6%
Cerebral Arteriovenous Malformation
5%
Lung Function
5%
Sputum
5%
Sputum Culture
5%
Antibiotics
5%
Dyspnea
5%
Bronchiolitis
5%
Embolization
5%
Epistaxis
5%
Allergic Bronchopulmonary Aspergillosis
5%
